Squarepoint’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,652
| Closed | -$191K | – | 3146 |
|
|
2024
Q4 | $191K | Buy |
10,652
+259
| +2% | +$4.64K | ﹤0.01% | 2400 |
|
|
2024
Q3 | $168K | Buy |
+10,393
| New | +$168K | ﹤0.01% | 2231 |
|
|
2024
Q2 | – | Sell |
-3,623
| Closed | -$70.6K | – | 2897 |
|
|
2024
Q1 | $70.6K | Sell |
3,623
-2,187
| -38% | -$42.6K | ﹤0.01% | 2292 |
|
|
2023
Q4 | $120K | Buy |
5,810
+4,813
| +483% | +$99.5K | ﹤0.01% | 2246 |
|
|
2023
Q3 | $31.7K | Buy |
997
+28
| +3% | +$891 | ﹤0.01% | 2364 |
|
|
2023
Q2 | $32.5K | Sell |
969
-2,729
| -74% | -$91.7K | ﹤0.01% | 2319 |
|
|
2023
Q1 | $154K | Buy |
+3,698
| New | +$154K | ﹤0.01% | 1940 |
|
|
2022
Q3 | – | Sell |
-925
| Closed | -$36K | – | 2447 |
|
|
2022
Q2 | $36K | Buy |
+925
| New | +$36K | ﹤0.01% | 1987 |
|
|
2022
Q1 | – | Sell |
-505
| Closed | -$49K | – | 2724 |
|
|
2021
Q4 | $49K | Buy |
+505
| New | +$49K | ﹤0.01% | 2413 |
|
|
2021
Q3 | – | Sell |
-391
| Closed | -$49K | – | 2671 |
|
|
2021
Q2 | $49K | Buy |
+391
| New | +$49K | ﹤0.01% | 2507 |
|
|
2021
Q1 | – | Sell |
-1,341
| Closed | -$122K | – | 2971 |
|
|
2020
Q4 | $122K | Buy |
1,341
+234
| +21% | +$21.3K | ﹤0.01% | 2300 |
|
|
2020
Q3 | $82K | Buy |
+1,107
| New | +$82K | ﹤0.01% | 2158 |
|
|
2020
Q2 | – | Sell |
-3,297
| Closed | -$238K | – | 2406 |
|
|
2020
Q1 | $238K | Buy |
+3,297
| New | +$238K | 0.01% | 1393 |
|